Semaglutide, a medication originally designed to treat type 2 diabetes, has recently gained significant attention as a weight ...

Get Instant Summarized Text (Gist) Semaglutide, typically used for type 2 diabetes, shows promise for type 1 diabetes patients using automated insulin pumps. In a 32-week trial, semaglutide ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

Semaglutide combined with automated insulin delivery enhances glucose control in type 1 diabetes, lowering insulin ...

Use of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic neuropathy (NAION) in ...

Novo Nordisk today announced headline results from STEP UP, a phase 3b trial in the global STEP programme. STEP UP is a ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...

The U.S. government has selected the second batch of drugs up for Medicare price negotiations under the Inflation Reduction ...

Diabetes affects over 37 million people in the United States, with most cases being type 2 diabetes. This condition, once ...